VVT MEDICAL
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6 Hasadna St, Kfar Saba, Central Distric...Phone Number
+972526045146Website
www.vvtmed.comRevenue
<$5 MillionIndustry
About VVT MEDICAL
VVT MEDICAL Org Chart
Chief Financial Officer
Is VVT MEDICAL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
VVT MEDICAL, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if VVT MEDICAL is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once VVT MEDICAL has new funding data
Click to see if VVT MEDICAL had a recent Job posting/layoffs
Earning: See what the market has to say on VVT MEDICAL recently announced quarterly report
Check if VVT MEDICAL has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when VVT MEDICAL launches new products
Congratulate Masked Content for being promoted to Masked Content at VVT MEDICAL
Recommended Actions
Find VP level buyers at VVT MEDICAL
Find 3 more new buyers
Company Profile Activity
Activity Insights
VVT MEDICAL is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VVT MEDICAL is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VVT MEDICAL.
VVT MEDICAL financials insights
Gather financial insights about VVT MEDICAL, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock/Share Issuance
$820K
VVT MEDICAL Tech Stack
A closer look at the technologies used by VVT MEDICAL
VVT MEDICAL News & Media
VVT Med Announces First Patients Treated with VVT’s ScleroSafe™ System in Italy
Leading Italian Vein Specialist Dr. Luca Palombi and His Team Successfully Treat First Patients in Italy Using the ScleroSafe™ System Leading Italian Vein Specialist Dr. Luca Palombi and His Team Successfully Treat First Patients in Italy Using the ScleroSafe™ SystemVVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery
Prospective Study Conducted at Holy Spirit Hospital in Mumbai Reports 95% Vein Occlusion Rate at 30 Prospective Study Conducted at Holy Spirit Hospital in Mumbai Reports 95% Vein Occlusion Rate at 30VVT Med Signs Largest European Distribution Agreement to Date; Distributor Joins as Investor
Five-Year Agreement Represents Approximately CAD $2.3 Million in Minimum Purchase Commitments | Distributor Joins as Investor in the Company’s Ongoing Private Placement Five-Year Agreement Represents Approximately CAD $2.3 Million in Minimum Purchase Commitments | Distributor Joins as Investor in the Company’s Ongoing Private PlacementDXI Capital Corp. Announces Proposed Acquisition of V.V.T. Med Ltd. and Exiteam Acquisition Corp.
Vancouver, British Columbia--(Newsfile Corp. - November 24, 2023) - DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to announce that it has entered into a non-binding letter of intent dated November 22, 2023 (the "LOI") with V.V.T. Med Ltd. ("VVT"), an Israeli corporation, and Exiteam Acquisition Corp. ("EAC"), a British Columbia corporation, pursuant to which DXI has agreed to acquire all of the issued and outstanding shares in the capital of VVT (the "VVT Shares")
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VVT MEDICAL
VVT Medical specializes in minimally invasive, office-based treatments for vein care, offering products like ScleroSafe and V-Block that utilize proprietary mechanochemical technology. Their solutions are designed to treat a wide range of vein diameters with enhanced precision and minimal side effects. The company targets healthcare providers and p... Read More